StatementBiotechnology-driven carbon revolution Fossil carbon is in nearly everything we use in our daily lives ranging from power and fuels to fibers, coatings, and materials used in our clothes, packaging, toys, and household goods. Virgin fossil … more ➔
The silent pandemic is not silent anymore COVID-19 is the acute pandemic, while antimicrobial resistance (AMR) is a silent, pandemic. New data makes the AMR pandemic visible, with the first global study of AMR estimating that 1.27 million people … more ➔
After the setback, what's next for bi... While the Nasdaq Biotechnology index saw a huge uplift during the pandemic (+ 77% since March 2020 until reaching a peak in August 2021), it lost 27% during the last six months vs a 11%/4% decline for … more ➔
BiologisationThe Next Big Thing: “Biologisation&#... The development of a sustainable bio-based economy will lead to disruptive economic changes. Venture capitalists focused on targets to drive digitisation in the past are now moving their attention to … more ➔
The Next Big Thing: "Biologisation&qu... The development of a sustainable bio-based economy will lead to disruptive economic changes. Venture capitalists focused on targets to drive digitisation in the past are now moving their attention to … more ➔
Join 900 US CEOs protest against Ukraine w...US Life Science leaders pledge to economically disengage from Russia. more ➔
Building on the advances made during the p... The pharmaceutical industry has made significant advances in collaboration over the past two years, and I have seen many examples amongst Pistoia Alliance members of the power of cooperative working. … more ➔
Vaccines burst 2021 biotech bubbleDespite a couple of notable ‘firsts’ for European public biotech financing, biotech’s COVID-19 bubble may be about to burst. Virus fears pushed both private and public investors toward biotech, but vaccination … more ➔
Supporting ulta-rare diseases Medicines for rare and paediatric diseases have been successfully enabled through the EU’s incentives framework. The number of medicines in development has risen significantly since the introduction … more ➔
mRNA – delivering on the promisesThe past two years could be called the years of messenger RNA (mRNA) technology, with two major biotech companies, BioNTech and Moderna, playing a crucial role in the development of vaccines against … more ➔
